Inspira Technologies OXY B.H.N. (NASDAQ:IINN) Stock Price Down 5.3% – Here’s Why

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) shares dropped 5.3% on Thursday . The stock traded as low as $1.39 and last traded at $1.42. 1,702,811 shares traded hands during mid-day trading, an increase of 383% from the average session volume of 352,435 shares. The stock had previously closed at $1.50.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Inspira Technologies OXY B.H.N. in a report on Friday, April 10th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

Inspira Technologies OXY B.H.N. Price Performance

The business has a 50 day simple moving average of $1.47 and a 200 day simple moving average of $0.93. The company has a quick ratio of 1.30, a current ratio of 1.56 and a debt-to-equity ratio of 0.08.

Hedge Funds Weigh In On Inspira Technologies OXY B.H.N.

Several hedge funds and other institutional investors have recently modified their holdings of IINN. Yorkville Advisors Global LP purchased a new stake in Inspira Technologies OXY B.H.N. during the 4th quarter worth approximately $1,605,000. Citadel Advisors LLC purchased a new position in shares of Inspira Technologies OXY B.H.N. in the third quarter worth $105,000. Finally, Kestra Advisory Services LLC purchased a new position in shares of Inspira Technologies OXY B.H.N. in the fourth quarter worth $71,000. 12.72% of the stock is owned by hedge funds and other institutional investors.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.